ERBB2 and breast cancer: Previous studies found that LINC00636 is up-regulated in human epidermal growth factor receptor-2 (HER-2) highly expressed breast cancer subtype [25] and pancreatic ductal adenocarcinoma [26] and could be the indicator of prognosis, which are consistent with results in this study.